{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:18:57Z","timestamp":1790259537129,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T00:00:00Z","timestamp":1450828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"crossref","award":["PIP 2011 6132761"],"award-info":[{"award-number":["PIP 2011 6132761"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007868","name":"SECyT","doi-asserted-by":"crossref","award":["05\/H127"],"award-info":[{"award-number":["05\/H127"]}],"id":[{"id":"10.13039\/501100007868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00213-015-4187-4","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T05:55:26Z","timestamp":1450850126000},"page":"1077-1086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression"],"prefix":"10.1007","volume":"233","author":[{"given":"Mar\u00eda Bel\u00e9n","family":"Poretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul S.","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Rask-Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Fiol","family":"de Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi B.","family":"Schi\u00f6th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela F.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Paola","family":"Carlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"key":"4187_CR1","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1111\/j.1469-445X.2000.tb00004.x","volume":"85","author":"G Aguilera","year":"2000","unstructured":"Aguilera G, Rabadan Diehl C (2000) Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat. Exp Physiol 85:19S\u201326S, Spec No","journal-title":"Exp Physiol"},{"key":"4187_CR2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/PSY.0b013e31816b1aaa","volume":"70","author":"T Ahrens","year":"2008","unstructured":"Ahrens T, Deuschle M, Krumm B, Van Der Pompe G, Den Boer JA, Lederbogen F (2008) Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosom Med 70:461\u2013467","journal-title":"Psychosom Med"},{"key":"4187_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/026988110001400101","volume":"14","author":"IM Anderson","year":"2000","unstructured":"Anderson IM, Nutt DJ, Deakin JF, British Association for Psychopharmacology (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. Journal of psychopharmacology 14:3\u201320","journal-title":"Journal of psychopharmacology"},{"key":"4187_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/frne.1993.1004","volume":"14","author":"FA Antoni","year":"1993","unstructured":"Antoni FA (1993) Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Frontiers in neuroendocrinology 14:76\u2013122","journal-title":"Frontiers in neuroendocrinology"},{"key":"4187_CR5","volume-title":"The Global Burden of Disease. 2004 Update","author":"W Bank","year":"2004","unstructured":"Bank W (2004) The Global Burden of Disease. 2004 Update. Oxford University Press, Oxford"},{"key":"4187_CR6","first-page":"185","volume":"29","author":"N Barden","year":"2004","unstructured":"Barden N (2004) Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. Journal of psychiatry & neuroscience : JPN 29:185\u2013193","journal-title":"Journal of psychiatry & neuroscience : JPN"},{"key":"4187_CR7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.pnpbp.2009.02.003","volume":"33","author":"RW Binfare","year":"2009","unstructured":"Binfare RW, Rosa AO, Lobato KR, Santos AR, Rodrigues AL (2009) Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Progress in neuro-psychopharmacology & biological psychiatry 33:530\u2013540","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"key":"4187_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(92)90459-M","volume":"572","author":"LS Brady","year":"1992","unstructured":"Brady LS, Gold PW, Herkenham M, Lynn AB, Whitfield HJ Jr (1992) The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain research 572:117\u2013125","journal-title":"Brain research"},{"key":"4187_CR9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1172\/JCI115086","volume":"87","author":"LS Brady","year":"1991","unstructured":"Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M (1991) Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. The Journal of clinical investigation 87:831\u2013837","journal-title":"The Journal of clinical investigation"},{"key":"4187_CR10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuropharm.2007.10.016","volume":"54","author":"PS Brocardo","year":"2008","unstructured":"Brocardo PS, Budni J, Kaster MP, Santos AR, Rodrigues AL (2008) Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 54:464\u2013473","journal-title":"Neuropharmacology"},{"key":"4187_CR11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0306-4530(79)90009-X","volume":"4","author":"KD Cairncross","year":"1979","unstructured":"Cairncross KD, Cox B, Forster C, Wren AF (1979) Olfactory projection systems, drugs and behaviour: a review. Psychoneuroendocrinology 4:253\u2013272","journal-title":"Psychoneuroendocrinology"},{"key":"4187_CR12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.psyneuen.2009.03.009","volume":"34","author":"LL Carpenter","year":"2009","unstructured":"Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH (2009) Dex\/CRH test cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology 34:1208\u20131213","journal-title":"Psychoneuroendocrinology"},{"key":"4187_CR13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","volume":"4","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Holmes A (2005) The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4:775\u2013790","journal-title":"Nat Rev Drug Discov"},{"key":"4187_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2003.11.032","volume":"485","author":"S Chaki","year":"2004","unstructured":"Chaki S, Nakazato A, Kennis L, Nakamura M, Mackie C, Sugiura M, Vinken P, Ashton D, Langlois X, Steckler T (2004) Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995\/CRA0450. European journal of pharmacology 485:145\u2013158","journal-title":"European journal of pharmacology"},{"key":"4187_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pbb.2004.09.001","volume":"79","author":"RA Oliveira De","year":"2004","unstructured":"De Oliveira RA, Cunha GM, Borges KD, De Bruin GS, Dos Santos Filho EA, Viana GS, De Bruin VM (2004) The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats. Pharmacology, biochemistry, and behavior 79:499\u2013506","journal-title":"Pharmacology, biochemistry, and behavior"},{"key":"4187_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.pbb.2008.02.011","volume":"89","author":"A Dhir","year":"2008","unstructured":"Dhir A, Kulkarni SK (2008) Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice. Pharmacology, biochemistry, and behavior 89:563\u2013571","journal-title":"Pharmacology, biochemistry, and behavior"},{"key":"4187_CR17","first-page":"3033","volume":"51","author":"VL Ellingrod","year":"1994","unstructured":"Ellingrod VL, Perry PJ (1994) Venlafaxine: a heterocyclic antidepressant. Am J Hosp Pharm 51:3033\u20133046","journal-title":"Am J Hosp Pharm"},{"key":"4187_CR18","volume-title":"The mouse brain in stereotaxic coordinates: compact 3rd","author":"KBJ Franklin","year":"2008","unstructured":"Franklin KBJ, Paxinos G (2008) The mouse brain in stereotaxic coordinates: compact 3rd. Accademic Press, New York, USA"},{"issue":"Suppl 1","key":"4187_CR19","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1097\/00004714-199704001-00002","volume":"17","author":"A Frazer","year":"1997","unstructured":"Frazer A (1997) Pharmacology of antidepressants. J Clin Psychopharmacol 17(Suppl 1):2S\u201318S","journal-title":"J Clin Psychopharmacol"},{"key":"4187_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2010.04.044","volume":"213","author":"P Frisch","year":"2010","unstructured":"Frisch P, Bilkei-Gorzo A, Racz I, Zimmer A (2010) Modulation of the CRH system by substance P\/NKA in an animal model of depression. Behav Brain Res 213:103\u2013108","journal-title":"Behav Brain Res"},{"key":"4187_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/299355a0","volume":"299","author":"GE Gillies","year":"1982","unstructured":"Gillies GE, Linton EA, Lowry PJ (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299:355\u2013357","journal-title":"Nature"},{"key":"4187_CR22","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.092012099","volume":"99","author":"G Griebel","year":"2002","unstructured":"Griebel G, Simiand J, Serradei Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P (2002a) Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proceedings of the National Academy of Sciences of the United States of America 99:6370\u20136375","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"4187_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1124\/jpet.301.1.333","volume":"301","author":"G Griebel","year":"2002","unstructured":"Griebel G, Simiand J, Steinberg R, Jung M, Gully D, Roger P, Geslin M, Scatton B, Maffrand JP, Soubrie P (2002b) 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylp henyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. The Journal of pharmacology and experimental therapeutics 301:333\u2013345","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"4187_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0893-133X(89)90007-9","volume":"2","author":"DE Grigoriadis","year":"1989","unstructured":"Grigoriadis DE, Pearsall D, De Souza EB (1989) Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2:53\u201360","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"4187_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0197-0186(94)00150-S","volume":"26","author":"M Heilig","year":"1995","unstructured":"Heilig M, Ekman R (1995) Chronic parenteral antidepressant treatment in rats: unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). Neurochemistry international 26:351\u2013355","journal-title":"Neurochemistry international"},{"key":"4187_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/edrv-17-2-187","volume":"17","author":"F Holsboer","year":"1996","unstructured":"Holsboer F, Barden N (1996) Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine reviews 17:187\u2013205","journal-title":"Endocrine reviews"},{"key":"4187_CR27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0028-3908(84)90130-8","volume":"23","author":"SM Jancsar","year":"1984","unstructured":"Jancsar SM, Leonard BE (1984) The effect of (+\/\u2212)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat. Neuropharmacology 23:1065\u20131070","journal-title":"Neuropharmacology"},{"key":"4187_CR28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00207458808990688","volume":"38","author":"JA Jesberger","year":"1988","unstructured":"Jesberger JA, Richardson JS (1988) Brain output dysregulation induced by olfactory bulbectomy: an approximation in the rat of major depressive disorder in humans? Int J Neurosci 38:241\u2013265","journal-title":"Int J Neurosci"},{"key":"4187_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","volume":"74","author":"JP Kelly","year":"1997","unstructured":"Kelly JP, Wrynn AS, Leonard BE (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74:299\u2013316","journal-title":"Pharmacol Ther"},{"key":"4187_CR30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuroscience.2011.07.077","volume":"194","author":"N Kokras","year":"2011","unstructured":"Kokras N, Sotiropoulos I, Pitychoutis PM, Almeida OF, Papadopoulou-Daifoti Z (2011) Citalopram-mediated anxiolysis and differing neurobiological responses in both sexes of a genetic model of depression. Neuroscience 194:62\u201371","journal-title":"Neuroscience"},{"key":"4187_CR31","first-page":"156","volume":"2","author":"ZC Liu","year":"2002","unstructured":"Liu ZC, Luo XN, Wang GH (2002) Corticotropin-releasing factor and major depression. Foreign Medical Sci (Section of Psychiatry) 2:156\u2013158","journal-title":"Foreign Medical. Sci. (Section of Psychiatry)"},{"key":"4187_CR32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pnpbp.2006.11.004","volume":"31","author":"DG Machado","year":"2007","unstructured":"Machado DG, Kaster MP, Binfare RW, Dias M, Santos AR, Pizzolatti MG, Brighente IM, Rodrigues AL (2007) Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Progress in neuro-psychopharmacology & biological psychiatry 31:421\u2013428","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"key":"4187_CR33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0091-3057(02)00881-X","volume":"73","author":"A Mar","year":"2002","unstructured":"Mar A, Spreekmeester E, Rochford J (2002) Fluoxetine-induced increases in open-field habituation in the olfactory bulbectomized rat depend on test aversiveness but not on anxiety. Pharmacology, biochemistry, and behavior 73:703\u2013712","journal-title":"Pharmacology, biochemistry, and behavior"},{"key":"4187_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/ENDO:8:1:13","volume":"8","author":"IE Marar","year":"1998","unstructured":"Marar IE, Amico JA (1998) Vasopressin, oxytocin, corticotrophin-releasing factor, and sodium responses during fluoxetine administration in the rat. Endocrine 8:13\u201318","journal-title":"Endocrine"},{"key":"4187_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(98)00981-1","volume":"262","author":"A Marcilhac","year":"1999","unstructured":"Marcilhac A, Anglade G, Hery F, Siaud P (1999) Olfactory bulbectomy increases vasopressin, but not corticotropin-releasing hormone, content in the external layer of the median eminence of male rats. Neuroscience letters 262:89\u201392","journal-title":"Neuroscience letters"},{"key":"4187_CR36","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1523\/JNEUROSCI.4734-03.2004","volume":"24","author":"Z Merali","year":"2004","unstructured":"Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H (2004) Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. The Journal of neuroscience : the official journal of the Society for Neuroscience 24:1478\u20131485","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"4187_CR37","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349:1498\u20131504","journal-title":"Lancet"},{"key":"4187_CR38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S1092852900025475","volume":"9","author":"CB Nemeroff","year":"2004","unstructured":"Nemeroff CB, Owens MJ (2004) Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis. CNS Spectr 9:23\u201331","journal-title":"CNS Spectr"},{"key":"4187_CR39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archpsyc.1988.01800300075009","volume":"45","author":"CB Nemeroff","year":"1988","unstructured":"Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988) Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Archives of general psychiatry 45:577\u2013579","journal-title":"Archives of general psychiatry"},{"key":"4187_CR40","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1126\/science.6334362","volume":"226","author":"CB Nemeroff","year":"1984","unstructured":"Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342\u20131344","journal-title":"Science"},{"key":"4187_CR41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0031-9384(92)90297-F","volume":"51","author":"S Noguchi","year":"1992","unstructured":"Noguchi S, Inukai T, Kuno T, Tanaka C (1992) The suppression of olfactory bulbectomy-induced muricide by antidepressants and antihistamines via histamine H1 receptor blocking. Physiology & behavior 51:1123\u20131127","journal-title":"Physiology & behavior"},{"key":"4187_CR42","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(24)38220-5","volume":"289","author":"S Okuyama","year":"1999","unstructured":"Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Nakazato A, Kumagai T, Okubo T, Tomisawa K (1999) Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. The Journal of pharmacology and experimental therapeutics 289:926\u2013935","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"4187_CR43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pnpbp.2014.09.012","volume":"56","author":"MB Poretti","year":"2015","unstructured":"Poretti MB, Rask-Andersen M, Kumar P, Rubiales de Barioglio S, Fiol de Cuneo M, Schioth HB, Carlini VP (2015) Ghrelin effects expression of several genes associated with depression-like behavior. Progress in neuro-psychopharmacology & biological psychiatry 56:227\u2013234","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"key":"4187_CR44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000126778","volume":"60","author":"FC Raadsheer","year":"1994","unstructured":"Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF (1994) Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:436\u2013444","journal-title":"Neuroendocrinology"},{"key":"4187_CR45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-2826.1995.tb00734.x","volume":"7","author":"C Rabadan-Diehl","year":"1995","unstructured":"Rabadan-Diehl C, Lolait SJ, Aguilera G (1995) Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat. Journal of neuroendocrinology 7:903\u2013910","journal-title":"Journal of neuroendocrinology"},{"key":"4187_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050638","volume":"138","author":"JP Redrobe","year":"1998","unstructured":"Redrobe JP, Bourin M, Colombel MC, Baker GB (1998) Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology 138:1\u20138","journal-title":"Psychopharmacology"},{"key":"4187_CR47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0278-5846(91)90081-B","volume":"15","author":"JS Richardson","year":"1991","unstructured":"Richardson JS (1991) Animal models of depression reflect changing views on the essence and etiology of depressive disorders in humans. Progress in neuro-psychopharmacology & biological psychiatry 15:199\u2013204","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"key":"4187_CR48","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/endo-115-3-882","volume":"115","author":"C Rivier","year":"1984","unstructured":"Rivier C, Rivier J, Mormede P, Vale W (1984) Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat. Endocrinology 115:882\u2013886","journal-title":"Endocrinology"},{"key":"4187_CR49","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. The American journal of psychiatry 163:1905\u20131917","journal-title":"The American journal of psychiatry"},{"key":"4187_CR50","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0024-3205(98)00027-7","volume":"62","author":"LV Scott","year":"1998","unstructured":"Scott LV, Dinan TG (1998) Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life sciences 62:1985\u20131998","journal-title":"Life sciences"},{"key":"4187_CR51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0091-3057(83)90364-7","volume":"18","author":"S Shibata","year":"1983","unstructured":"Shibata S, Watanabe S, Liou SY, Ueki S (1983) Effects of adrenergic blockers on the inhibition of muricide by desipramine and noradrenaline injected into the amygdala in olfactory bulbectomized rats. Pharmacology, biochemistry, and behavior 18:203\u2013207","journal-title":"Pharmacology, biochemistry, and behavior"},{"key":"4187_CR52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","volume":"29","author":"C Song","year":"2005","unstructured":"Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neuroscience and biobehavioral reviews 29:627\u2013647","journal-title":"Neuroscience and biobehavioral reviews"},{"key":"4187_CR53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"4187_CR54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2826.2008.01704.x","volume":"20","author":"LQ Stewart","year":"2008","unstructured":"Stewart LQ, Roper JA, Young WS 3rd, O\u2019Carroll AM, Lolait SJ (2008) Pituitary-adrenal response to acute and repeated mild restraint, forced swim and change in environment stress in arginine vasopressin receptor 1b knockout mice. Journal of neuroendocrinology 20:597\u2013605","journal-title":"Journal of neuroendocrinology"},{"key":"4187_CR55","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1124\/jpet.300.3.1085","volume":"300","author":"SC Stout","year":"2002","unstructured":"Stout SC, Owens MJ, Nemeroff CB (2002) Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. The Journal of pharmacology and experimental therapeutics 300:1085\u20131092","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"4187_CR56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2007.07.018","volume":"186","author":"AH Swiergiel","year":"2008","unstructured":"Swiergiel AH, Leskov IL, Dunn AJ (2008) Effects of chronic and acute stressors and CRF on depression-like behavior in mice. Behav Brain Res 186:32\u201340","journal-title":"Behav Brain Res"},{"key":"4187_CR57","volume-title":"Pharmacotherapy: A Pathophysiologic Approach","author":"CJ Teter","year":"2008","unstructured":"Teter CJ, Kando JC, Wells BG (2008) Major depressive disorder. In: DiPiro RLTJT, Yee GC, Matke GR, Wells BG, Posey LM (eds) Pharmacotherapy: A Pathophysiologic Approach. The McGraw-Hill Companies, Inc., Columbus, OH, USA"},{"key":"4187_CR58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0006-8993(85)90501-3","volume":"335","author":"Y Tizabi","year":"1985","unstructured":"Tizabi Y, Skofitsch G, Jacobowitz DM (1985) Effect of chronic reserpine and desmethylimipramine treatment on CRF-like immunoreactivity of discrete brain areas of rat. Brain research 335:389\u2013391","journal-title":"Brain research"},{"key":"4187_CR59","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1601-183X.2008.00402.x","volume":"7","author":"L Uriguen","year":"2008","unstructured":"Uriguen L, Arteta D, Diez-Alarcia R, Ferrer-Alcon M, Diaz A, Pazos A, Meana JJ (2008) Gene expression patterns in brain cortex of three different animal models of depression. Genes Brain Behav 7:649\u2013658","journal-title":"Genes Brain Behav"},{"key":"4187_CR60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","volume":"428","author":"K Pett Van","year":"2000","unstructured":"Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191\u2013212","journal-title":"J Comp Neurol"},{"key":"4187_CR61","first-page":"27","volume":"18","author":"H Weingartner","year":"1982","unstructured":"Weingartner H, Silberman E (1982) Models of cognitive impairment: cognitive changes in depression. Psychopharmacology bulletin 18:27\u201342","journal-title":"Psychopharmacology bulletin"},{"key":"4187_CR62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","volume":"2","author":"ML Wong","year":"2001","unstructured":"Wong ML, Licinio J (2001) Research and treatment approaches to depression. Nature reviews Neuroscience 2:343\u2013351","journal-title":"Nature reviews. Neuroscience"},{"key":"4187_CR63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.npep.2012.03.003","volume":"46","author":"J Yang","year":"2012","unstructured":"Yang J, Pan YJ, Yin ZK, Hai GF, Lu L, Zhao Y, Wang DX, Wang H, Wang G (2012) Effect of arginine vasopressin on the behavioral activity in the behavior despair depression rat model. Neuropeptides 46:141\u2013149","journal-title":"Neuropeptides"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-4187-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-015-4187-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-4187-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T22:32:54Z","timestamp":1748730774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-015-4187-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["4187"],"URL":"https:\/\/doi.org\/10.1007\/s00213-015-4187-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}